Medical device manufacturer Dymicron has announced the appointment of Ted Bird as Executive Vice President, Corporate Development, and Chief Strategy Officer. In the role, Bird will oversee Dymicron's corporate strategy, business & market development, investor relations, marketing, and commercialization. He will be based out of Charleston, SC, and report directly to company President and Chief Operating Officer at Dymicron Jeff Bennett.
Bird brings over 35 years of global commercial experience in the medical device space to the team at Dymicron. He most recently was the Chief Commercial Officer at Titan Spine and prior to that served in leadership positions at Johnson & Johnson as well as Medtronic.
"I am excited to join the Dymicron team to help introduce an extraordinary next-generation artificial cervical disc to the global spine community. This product is unique in the market due to its innovative composition, which utilizes a proprietary polycrystalline diamond material, and its patented Tri-Lobe articulating design. The exceptional durability of polycrystalline diamond virtually eliminates the risks of artificial disc wear debris for the lifetime of the patient. At the same time, the Tri-Lobe design mimics the natural kinematics and motion of a normal disc." said Bird
Bird graduated from Brown University and outside of work enjoys spending time with his family, traveling and sailing.